AANEM advocacy efforts are building congressional support and increasing awareness of the issues impacting electrodiagnostic (EDX) medicine.
As a result of meetings between congressional offices and AANEM advocates on Capitol Hill, as well as several emails sent by AANEM members at-large, a number of Senate offices have become interested in helping the community address the issue of quality and access to care in EDX medicine. Many offices are concerned that reductions in reimbursement would continue to undermine patient care, particularly when considering the proliferation of fraud and abuse, and seek to engage the Centers for Medicare and Medicaid Services (CMS) to address ongoing challenges.
Senator Amy Klobuchar (D-MN) and Lisa Murkowski (R-AK) asked their colleagues to join a sign on letter to CMS asking the agency to work with the stakeholder community on quality-based solutions and to report on any efforts to curb fraud and abuse in EDX medicine, resulting in the following Senate offices joining the letter:
• Senator Richard Burr (R-NC)
• Senator Chris Coons (D-DE)
• Senator Kristen Gillibrand (D-NY)
• Senator Angus King (I-ME)
• Senator Amy Klobuchar (D-MN)
• Senator Jeff Merkley (D-OR)
• Senator Lisa Murkowski (R-AK)
• Senator Dan Sullivan (R-AK)
The letter also served as a crucial tool to raise awareness among Senators of issues impacting EDX medicine. Over half the congressional offices in the Senate received constituent outreach regarding these issues and the letter, and nearly 20 Senate offices expressed significant interest in these issues.
The Senate letter follows recommendations in the annual appropriations bills for CMS to take deliberative action with stakeholders to promote quality and access in EDX medicine. CMS is now facing mounting pressure to work with the community and policymakers in a collaborative and productive fashion.